Abstract
Studies of the etiology of melanoma have identified number of nondysplastic and clinically dysplastic melanocytic nevi (“atypical nevi”, hereafter called dysplastic nevi) as significant risk factors for melanoma [1–10], whether nevi were counted on the entire body or on the arms alone. Theoretically, a count of nevi on the entire body surface compared to a count of nevi on a specific anatomic site should have greater power to discriminate between populations at risk and those not at risk due to the higher number of nevi. However, few studies of total body nevus counts have been carried out, as they require trained clinicians, considerable time from subjects and observers and private examination space. The present analysis was conducted to determine whether nevi counted and recorded by anatomic site correlated with total body nevi counts, and to determine which body sites best correlated with total body counts. Sensitivity and specificity were examined to evaluate whether counts of nevi would be useful as a clinical screening tool for cutaneous melanoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459–68.
Kelly JW, Holly EA, Shpall SN, et al. The distribution of melanocytic naevi in melanoma patients and control subjects. Australas J Dermatol 1989;30:1–8.
Swerdlow AJ, English J, Mackie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986;292:1555–9.
Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990;66:387–95.
Holman CDJ, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257–66.
Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985;35:297–300.
Elwood JM, Williamson C, Stapleton PJ. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer 1986;53:65–74.
Osterlind A, Tucker MA, Hgu-Jensen K, et al. The Danish case-control study of cutaneous malignant melanoma I. Importance of host factors. J Cancer 1988;42:200–6.
Halpern AC, Guerry D, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol 1991;127:995–9.
Augustsson A, Stierner U, Rosdahl I, et al. Common and dysplastic nevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol 1990;71:518–24.
Kelly JW, Crutcher WA, Sagebiel RW. The clinical diagnosis of dysplastic melanocytic naevi—a clinico-pathologic correlation. J Am Acad Dermatol 1986;14:1044–52.
Breslow NE, Day NE. Statistical methods in cancer research 1: The analysis of case-control studies. Lyon: IARC, 1980.
Dixon WJ, Brown MG, Engelman L. Biomedicai Computer Programs. Berkeley: University of California Press, 1983.
SAS Institute Inc. SAS Procedures Guide. 6.03, 1988.
Lee G, Massa MC, Welykyj S, et al. Yield from total skin examination and effectiveness of skin cancer awareness program. Findings in 874 new dermatology patients. Cancer 1991;67:202–5.
English JSC, Swerdlow AJ, MacKie RM, et al. Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol 1988;118:641–4.
Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985;45:1855–61.
Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma. Cancer 1980;46:1787–94.
Gallagher RP, McLean DI, Yang CP, et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Derm 1990;126:770–6.
Gallagher RP, McLean DI, Yang CP, et al. Anatomic distribution of acquired melanocytic nevi in white children. A comparison with melanoma: the Vancouver Mole Study. Arch Derm 1990;126:463–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Holly, E.A., Kelly, J.W., Ahn, D.K., Shpall, S.N., Rosen, J.I. (1994). Risk of cutaneous melanoma by number of melanocytic nevi and correlation of nevi by anatomic site. In: Gallagher, R.P., Elwood, J.M. (eds) Epidemiological Aspects of Cutaneous Malignant Melanoma. Developments in Oncology, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2626-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2626-1_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6126-8
Online ISBN: 978-1-4615-2626-1
eBook Packages: Springer Book Archive